Sign inJoin waitlistJoin the waitlist

Hope Rugo

Physician · City of Hope

Credentials: · ·

History

City of Hope
2025–Present

Hematology and Medical Oncology
University of California (San Francisco) School of Medicine
1987–1990
University of California-San Francisco
1984–1987
Perelman School of Medicine at the University of Pennsylvania
1980–1984

Research

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
New England Journal of Medicine · 2018 · 3,425 citations
Palbociclib and Letrozole in Advanced Breast Cancer
New England Journal of Medicine · 2016 · 2,333 citations
Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer
New England Journal of Medicine · 2012 · 2,319 citations

Laura Esserman
67 papers
Sara Tolaney
67 papers · 1 as a fellow
JO
Joyce O'Shaughnessy
61 papers
Michelle Melisko
60 papers · 1 as a fellow
Jo Chien
58 papers · 1 as a fellow
Angela DeMichele
56 papers
Eric Winer
50 papers
AB
Adam Brufsky
49 papers
Sara Hurvitz
45 papers
Lisa Carey
42 papers
Aditya Bardia
41 papers
DY
Denise Yardley
39 papers

Grants

Portable, Patient-Administered Scalp Cooling Cap to Reduce Provider Burden, Improve Patient Access, and Improve Patient Outcomes for Chemotherapy-Induced Alopecia
National Cancer Institute · R44
PI · $1M · Cooler Heads Care Inc
2021–2026
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $6.6K · University of California, San Francisco
2004–2006

Clinical trials

Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
Daehwa Pharmaceutical Co., Ltd.
2018–2022
A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
University of California, San Francisco
2015–2021
Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)
Principal investigator · Terminated · Phase 2
GTx
2015–2017
Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer
Principal investigator · Terminated · Phase 2
Hope Rugo, MD
2012–2016